New formulation of loteprednol for dry eye

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

Medicolleague

Membership Revoked
Removed
Joined
Nov 15, 2020
Messages
3
Reaction score
1
Will this be better than Lotemax?

Excerpt:
Eysuvis utilizes Kala’s Ampplify mucus-penetrating particle (MPP) drug delivery technology to enhance penetration of loteprednol etabonate into target tissue on the ocular surface. Loteprednol etabonate targets the immune responses that drive acute dry eye disease flares. Prior to Eysuvis, there were no FDA-approved ocular corticosteroids for the treatment of dry eye disease.


Members don't see this ad.
 
Will this be better than Lotemax?

Excerpt:
Eysuvis utilizes Kala’s Ampplify mucus-penetrating particle (MPP) drug delivery technology to enhance penetration of loteprednol etabonate into target tissue on the ocular surface. Loteprednol etabonate targets the immune responses that drive acute dry eye disease flares. Prior to Eysuvis, there were no FDA-approved ocular corticosteroids for the treatment of dry eye disease.


Probably not. Reformulating an old ingredient and charging $300 a month for it doesn't help my patients at all. I don't care how the marketing teams tries to hype it up.
 
  • Like
Reactions: KHE
Another medication which will be insanely priced, which no insurance plan will cover unless you submit multiple prior authorizations documentation "failure" of the patient on "artificial tears" and "azelastine" and even then probably not so the reps will then visit you and aggressively push you to give out "coupons" that contain a secret code or a 1-800 number the patient can call to "register" with the company and maybe get the medication direction from the company.

Of course, virtually no patients will want to do this and that will be when your office gets the call from the patient asking for you to prescribe "something else" and send the prescription to their preferred CVS or Walgreens pharmacy. Or Express Scripts.
 
Top